Prednisolone (30-60 mg/day) for diseases other than AD decreases amyloid β-peptides in CSF

Neurology

Volumn 58, Issue 9, 2002, Pages 1415-1418

  Tokuda, Takahiko ^a   Oide, T ^a   Tamaoka, A ^a   Ishii, K ^a   Matsuno, S ^a   Ikeda, S ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PREDNISOLONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CRANIAL NEUROPATHY; DEMENTIA; DOSE RESPONSE; DRUG EFFECT; EYE DISEASE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TRIGEMINUS NEURALGIA;

EID: 0037076502     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.9.1415     Document Type: Article

References (10)

1. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
2. The importance of inflammatory mechanisms in Alzheimer disease
3. Inflammation and Alzheimer's disease
4. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
5. Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients
6. A randomized controlled trial of prednisone in Alzheimer's disease
7. Cessation of cerebral hemorrhage recurrence associated with corticosteroid treatment in a patient with cerebral amyloid angiopathy
8. Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
9. Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42(43) are elevated in Down's syndrome
10. Amyloid β protein species in cerebrospinal fluid and in brain from patients with Down's syndrome